Dexmed/Buspirone Synergism on Shivering

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Hypothermia
Interventions
DRUG

dexmedetomidine

Dexmedetomidine (delivered by a computer-controlled IV infusion to target a plasma concentration of 0.6 ng/mL) will be given during controlled hypothermia

DRUG

buspirone

Buspirone, 60 mg orally, will be given during controlled hypothermia.

DRUG

Bus and Dex

the combination of 60 mg buspirone and dexmedetomidine (target plasma concentration of 0.6 ng/mL) will be given during controlled hypothermia

DRUG

Control

No drugs given during controlled hypothermia

Trial Locations (1)

40202

Outcomes Research Institute, University of Louisville, Louisville

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00334360 - Dexmed/Buspirone Synergism on Shivering | Biotech Hunter | Biotech Hunter